Arrakis Therapeutics Announces $75 Million Series B Financing to Advance a New Class of Small-Molecule Medicines Targeting RNA

from Venture Capital Access Online: Latest Venture Capital and Private Equity News http://bit.ly/2XoFgUM
via IFTTT